Meghmani Organics Limited

NSEI:MOL Stock Report

Market Cap: ₹12.5b

Meghmani Organics Balance Sheet Health

Financial Health criteria checks 3/6

Meghmani Organics has a total shareholder equity of ₹15.4B and total debt of ₹7.3B, which brings its debt-to-equity ratio to 47%. Its total assets and total liabilities are ₹30.2B and ₹14.8B respectively. Meghmani Organics's EBIT is ₹1.5B making its interest coverage ratio 1.7. It has cash and short-term investments of ₹264.9M.

Key information

46.99%

Debt to equity ratio

₹7.26b

Debt

Interest coverage ratio1.7x
Cash₹264.88m
Equity₹15.45b
Total liabilities₹14.76b
Total assets₹30.21b

Recent financial health updates

Recent updates

Analysis Article Feb 07

Meghmani Organics (NSE:MOL) Takes On Some Risk With Its Use Of Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Aug 06

Meghmani Organics (NSE:MOL) Will Want To Turn Around Its Return Trends

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Analysis Article Jun 03

Meghmani Organics Limited's (NSE:MOL) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Meghmani Organics Limited ( NSE:MOL ) shares have continued their recent momentum with a 28% gain in the last month...
Analysis Article Mar 23

Here's Why Meghmani Organics (NSE:MOL) Can Afford Some Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Dec 24

Meghmani Organics Limited's (NSE:MOL) Low P/S No Reason For Excitement

You may think that with a price-to-sales (or "P/S") ratio of 1.2x Meghmani Organics Limited ( NSE:MOL ) is a stock...
Analysis Article Aug 23

Optimistic Investors Push Meghmani Organics Limited (NSE:MOL) Shares Up 28% But Growth Is Lacking

The Meghmani Organics Limited ( NSE:MOL ) share price has done very well over the last month, posting an excellent gain...
Analysis Article Feb 23

Risks To Shareholder Returns Are Elevated At These Prices For Meghmani Organics Limited (NSE:MOL)

It's not a stretch to say that Meghmani Organics Limited's ( NSE:MOL ) price-to-sales (or "P/S") ratio of 1.4x right...
Analysis Article Jun 05

Meghmani Organics (NSE:MOL) Is Due To Pay A Dividend Of ₹1.40

The board of Meghmani Organics Limited ( NSE:MOL ) has announced that it will pay a dividend of ₹1.40 per share on the...
Analysis Article Jan 24

Meghmani Organics (NSE:MOL) Could Be Struggling To Allocate Capital

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article May 09

Robust Earnings May Not Tell The Whole Story For Meghmani Organics (NSE:MOL)

The recent earnings posted by Meghmani Organics Limited ( NSE:MOL ) were solid, but the stock didn't move as much as we...
Analysis Article Feb 14

Earnings Working Against Meghmani Organics Limited's (NSE:MOL) Share Price

When close to half the companies in India have price-to-earnings ratios (or "P/E's") above 21x, you may consider...

Financial Position Analysis

Short Term Liabilities: MOL's short term assets (₹13.2B) exceed its short term liabilities (₹12.3B).

Long Term Liabilities: MOL's short term assets (₹13.2B) exceed its long term liabilities (₹2.5B).


Debt to Equity History and Analysis

Debt Level: MOL's net debt to equity ratio (45.3%) is considered high.

Reducing Debt: MOL's debt to equity ratio has increased from 22.3% to 47% over the past 5 years.

Debt Coverage: MOL's debt is well covered by operating cash flow (30.5%).

Interest Coverage: MOL's interest payments on its debt are not well covered by EBIT (1.7x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/20 21:47
End of Day Share Price 2026/05/20 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Meghmani Organics Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.